Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.24
-0.4287-1.81%
Post-market: 23.16-0.0763-0.33%16:10 EDT
Volume:3K
Turnover:60.42K
Market Cap:3.02M
PE:- -
High:23.66
Open:23.66
Low:23.01
Close:23.67
52wk High:24.09
52wk Low:14.14
Shares:130.00K
Float Shares:130.00K
Volume Ratio:0.48
T/O Rate:2.01%
Dividend:0.77
Dividend Rate:3.32%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

US Stocks-Wall St Set for Higher Open After Retail Earnings; Moderna Soars

Reuters
·
Aug 19

Moderna extends rally, shares up 89% to $118.99 after melonoma data

TIPRANKS
·
Aug 19

Moderna upgraded to Outperform from Market Perform at William Blair

TIPRANKS
·
Aug 19

Biotech Stocks Jump Premarket After Moderna's Melanoma Vaccine with Merck Succeeds in Large Trial

THOMSON REUTERS
·
Aug 19

The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn

Dow Jones
·
Aug 19

Moderna Shares More than Double Premarket; Last up 103%

THOMSON REUTERS
·
Aug 19

Stocks to Watch: Oracle, SK Hynix, Moderna, Unitree

Dow Jones
·
Aug 19

US Stocks-Wall St Futures Flat After Tech Rout; Iran Tensions, Retail Earnings in Focus

Reuters
·
Aug 19

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 19

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Twist Bioscience Assists Anthropic in Testing Whether Claude Can Accelerate Drug-Design Process

Dow Jones
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Moderna Vaccine Cuts Recurrence and Spread of High-Risk Melanoma, Raising New Treatment Hope

Reuters
·
Aug 19

Moderna jumps 54% to $97.52 after Phase 3 INTerpath-001 trial met endpoints

TIPRANKS
·
Aug 19

Moderna Shares Extend Gains; Last up 46.9% Premarket

THOMSON REUTERS
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Co, Moderna Announce Positive Results from Phase 3 Interpath-001 Trial for Patients with Completely Resected Stage Iib-Iv Melanoma

THOMSON REUTERS
·
Aug 19